Stryker Co. (NYSE:SYK) Shares Purchased by Cyrus J. Lawrence LLC

Cyrus J. Lawrence LLC lifted its position in Stryker Co. (NYSE:SYK) by 1.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 23,931 shares of the medical technology company’s stock after acquiring an additional 269 shares during the period. Stryker accounts for 1.7% of Cyrus J. Lawrence LLC’s holdings, making the stock its 27th largest position. Cyrus J. Lawrence LLC’s holdings in Stryker were worth $8,616,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the company. Sciencast Management LP acquired a new stake in shares of Stryker in the fourth quarter worth approximately $3,035,000. ZEGA Investments LLC acquired a new stake in shares of Stryker in the fourth quarter worth approximately $1,267,000. Millstone Evans Group LLC purchased a new position in Stryker during the fourth quarter worth approximately $555,000. TD Private Client Wealth LLC lifted its position in Stryker by 4.4% during the fourth quarter. TD Private Client Wealth LLC now owns 5,157 shares of the medical technology company’s stock worth $1,857,000 after buying an additional 217 shares in the last quarter. Finally, Antonelli Financial Advisors LLC purchased a new position in Stryker during the fourth quarter worth approximately $773,000. 77.09% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts recently commented on SYK shares. Royal Bank of Canada lifted their price objective on Stryker from $425.00 to $435.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 29th. The Goldman Sachs Group set a $422.00 price objective on Stryker in a research report on Tuesday, March 4th. Stifel Nicolaus lifted their price objective on Stryker from $400.00 to $440.00 and gave the stock a “buy” rating in a research report on Wednesday, January 29th. Truist Financial lifted their price objective on Stryker from $409.00 to $413.00 and gave the stock a “hold” rating in a research report on Thursday, January 30th. Finally, Argus set a $450.00 target price on Stryker in a research report on Monday, February 3rd. Five investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $421.90.

Insider Buying and Selling

In other news, Director Allan C. Golston sold 2,458 shares of the company’s stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $383.07, for a total transaction of $941,586.06. Following the completion of the transaction, the director now directly owns 14,895 shares of the company’s stock, valued at approximately $5,705,827.65. This represents a 14.16 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Ronda E. Stryker sold 201,392 shares of the company’s stock in a transaction dated Friday, January 31st. The stock was sold at an average price of $392.24, for a total value of $78,993,998.08. Following the transaction, the director now directly owns 3,642,075 shares of the company’s stock, valued at approximately $1,428,567,498. This represents a 5.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 5.90% of the stock is currently owned by insiders.

Stryker Price Performance

SYK stock opened at $371.38 on Friday. Stryker Co. has a 12-month low of $314.93 and a 12-month high of $406.19. The company has a market capitalization of $141.71 billion, a PE ratio of 47.86, a P/E/G ratio of 2.93 and a beta of 0.95. The company has a current ratio of 1.95, a quick ratio of 1.32 and a debt-to-equity ratio of 0.59. The business’s fifty day moving average price is $384.28 and its 200 day moving average price is $373.93.

Stryker (NYSE:SYK) last released its earnings results on Tuesday, January 28th. The medical technology company reported $4.01 EPS for the quarter, topping the consensus estimate of $3.87 by $0.14. Stryker had a return on equity of 23.58% and a net margin of 13.25%. During the same quarter in the previous year, the business posted $3.46 earnings per share. On average, sell-side analysts anticipate that Stryker Co. will post 13.47 EPS for the current year.

Stryker Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 30th. Investors of record on Monday, March 31st will be paid a dividend of $0.84 per share. The ex-dividend date of this dividend is Monday, March 31st. This represents a $3.36 annualized dividend and a yield of 0.90%. Stryker’s payout ratio is 43.30%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.